Worth Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Sell
4,125
-6,712
-62% -$786K 0.17% 112
2026
Q1
$1.3M Buy
10,837
+5,340
+97% +$616K 0.49% 54
2025
Q4
$579K Buy
+5,497
New +$516K 0.25% 72
2023
Q3
Sell
-1,192
Closed -$138K 285
2023
Q2
$138K Buy
1,192
+192
+19% +$21.8K 0.11% 110
2023
Q1
$106K Hold
1,000
0.08% 126
2022
Q4
$111K Hold
1,000
0.08% 109
2022
Q3
$86K Sell
1,000
-14,488
-94% -$1.29M 0.06% 109
2022
Q2
$1.41M Sell
15,488
-4,099
-21% -$363K 0.96% 19
2022
Q1
$1.78M Buy
+19,587
New +$1.54M 1.16% 19

Other funds holding MRK

Worth Asset Management's MRK Position: Q2 2026 in Review

Worth Asset Management reduced its Merck (MRK) stake by 62% in Q2 2026, selling an estimated $786K and leaving 4,125 shares worth $530K. The position accounts for 0.17% of the portfolio, ranked #112.

Worth Asset Management first reported a position in MRK in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.78M in Q1 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Worth Asset Management held 4,125 shares of Merck worth $530K as of Q2 2026.
  • Worth Asset Management sold 6,712 Merck shares in Q2 2026, an estimated $786K.
  • Merck made up 0.17% of Worth Asset Management's portfolio in Q2 2026, its #112 holding.
  • Worth Asset Management first reported a position in Merck in Q1 2022 and has held it in 9 quarters since.
  • Worth Asset Management's Merck position peaked at $1.78M in Q1 2022.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.